Aurovitas

Aurovitas is a pharmaceutical company that serves as the European generic medicines division of the global pharmaceutical leader Aurobindo Pharma. The company specializes in the commercialization of a diverse portfolio of high-quality generic drugs across key therapeutic areas, including cardiovascular, central nervous system, and anti-infective treatments. Established through the strategic acquisition of Actavis's commercial operations in several Western European countries in 2014, Aurovitas operates primarily in Spain, Portugal, and Italy. It leverages Aurobindo's extensive global manufacturing infrastructure and R&D capabilities to provide affordable healthcare solutions to pharmacies and hospitals. Aurovitas is committed to expanding its market presence through continuous product launches and a focus on supply chain excellence. The company plays a vital role in enhancing patient access to essential medicines within the European healthcare landscape.